← back to search

Brian J. Grindel

The University of Texas Health Science Center at Houston · US
Area of research
Cell Biology · Cancer Research
Research interest
Research interests include Perlecan, Tumor microenvironment, Cancer research, NF-κB, Prostate, and Matrilysin.
h-index
citations
72
works
2
NIH funding
primary concept
email

Recent publications

Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
Oncotarget 2016cited by 32position: firstdoi
Transcriptional Activation by NFκB Increases Perlecan/HSPG2 Expression in the Desmoplastic Prostate Tumor Microenvironment
Journal of Cellular Biochemistry 2014cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mary C. Farach‐Carson · The University of Texas Health Science Center at Houston2 papers (2014–2016)Lewis W. Francis · Houston Methodist1 papers (2014–2014)Quanlin Li · Shenzhen University1 papers (2016–2016)Curtis R. Warren · Harvard Stem Cell Institute1 papers (2014–2014)Leland W.K. Chung · Hong Kong Polytechnic University1 papers (2016–2016)Rebecca S. Arnold · Emory University1 papers (2016–2016) · 1 papers (2016–2016)Majd Zayzafoon · University of Alabama at Birmingham1 papers (2016–2016)Daniel D. Carson · University of Houston1 papers (2014–2014)Mark Muldoon · University of Manchester1 papers (2016–2016)John A. Petros · Emory University1 papers (2016–2016)